Best Targeted Therapy Hospitals in Italy

The state-of-the-art Targeted Therapy services offered by IRCCS Ospedale San Raffaele, using modern precision oncology techniques and internationally recognized treatment protocols, have been operational in milan, Italy. Founded in 1971, the SSN accredited hospital has 1350 beds and provides cancer care facilities for all its local and overseas patients.

Targeted therapy is medicine developed to target specific molecular changes or proteins that affect the growth and survival of cancer cells. It is applicable only to certain cancers in which a relevant biomarker or genetic alteration is present. Prior to the start of the therapy, doctors may perform tumor profiling or molecular testing to check if the targeted medicine can help the patient.

At Casa di Cura La Madonnina, targeted therapy is offered using state-of-the-art molecular diagnostic instruments and protocols. The SSN accredited facility has been functioning since 1958 and is located in milan, Italy. The hospital has 560 beds and serves both international and local patients.

Targeted therapy is designed to combat cancer by utilising specific characteristics of tumour molecular structure. Based on the biomarker, targeted drugs could be administered to halt the functioning of proteins or biological pathways responsible for causing cancer. The role of the medical staff involved in the procedure is to determine the treatment plan based on factors such as pathology, molecular diagnostic results, disease stage, and previous treatments.

The state-of-the-art Targeted Therapy services offered by IRCCS Policlinico San Donato, using modern precision oncology techniques and internationally recognized treatment protocols, have been operational in milan, Italy. Founded in 1969, the SSN accredited hospital has 430 beds and provides cancer care facilities for all its local and overseas patients.

Targeted therapy is medicine developed to target specific molecular changes or proteins that affect the growth and survival of cancer cells. It is applicable only to certain cancers in which a relevant biomarker or genetic alteration is present. Prior to the start of the therapy, doctors may perform tumor profiling or molecular testing to check if the targeted medicine can help the patient.

With advanced oncology infrastructure, IRCCS Ospedale Galeazzi- Sant’Ambrogio offers Targeted Therapy for patients with cancers that contain specific treatable molecular alterations. Established in 1963, the SSN accredited hospital is located in milan, Italy, and has 560 beds.

Targeted medicines may block signals that allow cancer cells to grow, divide, spread, or develop new blood vessels. The choice of therapy depends on the cancer type, stage, molecular profile, and previous treatments. Comprehensive diagnostic and biomarker testing is performed when appropriate to guide treatment selection.